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Chemotherapeutic agents for cancer are highly toxic to healthy tissues and hence alternative medicine avenues are widely
researched.MajorityoftherecentstudiesonalternativemedicinesuggestedthatAmoora rohituka possessesconsiderableantitumor
and antibacterial properties. In this work, rohituka and chittagonga, fractionated with petroleum ether, dichloromethane, and
ethanol, were explored for their anticancer potential against two breast cancer (MCF-7 and HTB-126) and three pancreatic
cancer (Panc-1, Mia-Paca2, and Capan1). The human foreskin ﬁbroblast, Hs68, was also included. Cytotoxicity of each extract
was analyzed using the MTT assay and label-free photonic crystal biosensor assay. A concentration series of each extract was
performed on the six cell lines. For MCF-7 cancer cells, the chittagonga (Pet-Ether and CH2Cl2)a n drohituka (Pet-Ether) extracts
induced cytotoxicity; the chittagonga (EtoAC) and rohituka (MeOH) extracts did not induce cytotoxicity. For HTB126, Panc-1,
Mia-Paca2, and Capan-1 cancer cells, only the chittagonga CH2Cl2 extract showed a signiﬁcant cytotoxic eﬀect. The extracts were
not cytotoxic to normal ﬁbroblast Hs68 cells, which may be correlated to the speciﬁcity of Amoora extracts in targeting cancerous
cells. Based on these results, further examination of the potential anticancer properties Amoora species and the identiﬁcation of
the active ingredients of these extracts is warranted.
1.Introduction
Cancer is one of the leading causes of death in the United
States, which is resulted by the uncontrollable division of
abnormal cells. Speciﬁcally, breast cancer is one of the most
common cancers worldwide with high mortality rate if diag-
nosed in the later stages. However, if discovered at an early
stage and with proper treatments, these cancerous cells could
be completely removed [1, 2]. Pancreatic cancer has a high
mortality rate and often cannot be detected at an early stage
due to the fact that symptoms do not appear until the disease
has advanced signiﬁcantly [3, 4]. Typical treatment regimes
include targeting the tumor with ionizing radiation, surgical
removal of tumor tissue, and chemotherapy. However, these
current cancer treatment methods also cause severe systemic
side eﬀects. For this reason, recent research has focused on
the search for alternative medicines extracted from plant-
based sources. The use of alternative medicines, especially
when used in conjunction with conventional cancer treat-
ments, can serve to mitigate the side eﬀects [5], enhance the
uptake of conventional medicines, and, bolster the immune
system to ﬁght the cancer. Since these medicines are primar-
ily extracts of naturally occurring ﬂora, their bioavailability
is less likely to induce severe immune responses.
Several species of the Amoora plant extract in many parts
of Bangladesh possess a multitude of medicinal properties2 Evidence-Based Complementary and Alternative Medicine
against inﬂammation, cancer, and diseases of the liver
[6–8]. One of the most common and the most studied
Amoora species, the Amoora rohituka,i sa ne v e r g r e e nt r e e
that grows wildly in the region and is planted in many
districts of Bangladesh [9]. It is traditionally used as herbal
medicine for cancer, tumor, liver, and spleen diseases.
The petroleum ether and methanol extracts of Amoora
rohituka are reported to possess good laxative potential
and can be developed to perform as safer gastrointestinal
agents [10]. Furthermore, Amoora rohituka extracts are also
known to possess antimicrobial activity [11]( w i t ha nI C 50
at ∼360µg/mL). The plant triterpenic acid, amooranin,
extracted from the bark of Amoora rohituka trees, has been
reported to possess signiﬁcant anticancer potential [7, 12].
In the earlier studies, amooranin has been shown to induce
apoptosis in breast carcinoma through caspase activity [13]
and is known to be eﬀective against breast cancer, colon
cancer, cervical cancer, and leukemia cell panels [14]. Besides
anticancer activity, amooranin is also known to induce the
reversal of multidrug resistance in human leukemia and
colon cancer cells lines [15]. An amooranin concentration
of 10µM or higher has been shown to cause a cytotoxic
response. One of the amooranin derivatives, amoorastatin,
has shown signiﬁcant inhibition activity against murine
P388 lymphocytic leukemia cell lines [16]. Furthermore,
chromone alkaloid rohitukine, a leading compound isolated
from Amoora rohituka, has shown anticancer eﬀect on non-
Hodgkin’s lymphoma as well as renal, prostate, colon, and
gastric cancers [17]. In addition, the rocaglamide derivatives
ofthe Amooracucullataspecieshavebeenreported topossess
potent antitumor activity against KB, BC, and NCI-H187
cancer cell lines [18]. Currently, little is known about the
bioactivity of Amoora chittagongaexcept that it is present in a
numberofsoutheasternAsiancountries,suchasBangladesh
and Thailand [19, 20]. The plant extracts explored in this
research are from the Mahogany family. The Meliaceae,o r
the Mahogany family, is a ﬂowering plant family of mostly
trees and shrubs (and a few herbaceous plants) in the order
Sapindales.
The majority of reports have investigated medicinal
properties of Amoora rohituka, but it is important to explore
the eﬀects of other less-studied species of Amoora on various
cancer cell lines. In this work, two species of the genus
Amoora, rohituka and chittagonga, were studied for their
anticancer potential on a panel of ﬁve human cancer cell
lines and one human foreskin ﬁbroblast cell line. This panel
consisted of the following cell lines: MCF-7 and HTB-126
(breast cancer), Panc-1, Mia-Paca2, and Capan1 (pancreatic
cancer), and Hs68 (ﬁbroblast cell).
The Amoora chittagonga was fractionated with pet-ether
(petroleum ether), CH2Cl2 (dichloromethane), and EtoAC
(ethanol), while Amoora rohituka was fractionated with pet-
ether and MeOH (methanol). Utilizing a conventional MTT
assay, the ﬁve extracts were tested on each cell line at four
concentrations ranging from 100µg/mL to 0.1µg/mL and
the IC50 values were determined. The results of the MTT
assay were then conﬁrmed using a label-free photonic crystal
(PC) biosensor assay. The PC biosensor provides an image
of the attachment of cells on the sensor surface before
and after the incubation with plant extracts, which can
determine the cytotoxicity eﬀects [11, 21]. These biosensors
are incorporated into the bottom of a 96- and 384-well stan-
dard microplate, which enables high-throughput screening
of multiple extracts and cancer cells lines simultaneously
and allows the rapid characterization of potential cytotoxic
compounds.
2.MaterialsandMethods
2.1. Plant Extracts. The extracts, Amoora chittagonga and
Amoora rohituka, were provided by Dr. Chowdhury from the
University of Dhaka at Bangladesh. Both Amoora rohituka
andchittagongastembarkwascollectedfromComilla,which
is in the Chittagong Division, Comilla District of Bangladesh
[22].
The plants were identiﬁed at the Bangladesh National
Herbarium, where voucher specimens have been deposited
under the accession numbers DACB-28927 [22]. The air-
dried and powdered stem bark (507.6g) was succes-
sively extracted with light petroleum ether (40◦–60◦),
dichloromethane, and methanol in a Soxhlet apparatus at an
elevated temperature. All three extracts were ﬁltered through
fresh cotton beds. The ﬁltrates were evaporated under
reduced pressure at 40◦C using a B¨ uchi rotary evaporator
to have gummy concentrates of petroleum ether (6.6g),
dichloromethane (4.3g), and methanol (11.6g) extracts.
Stock solutions of the dried extracts were prepared by
dissolving them in ethanol to a concentrations of 25mg/mL
orhigher.Theywerediluteddirectlyincellculturemediaand
tested on the cancer cell lines at concentrations of 10, 25, 50,
and 100µg/mL. Testing on normal cell line was performed
at concentrations of 0.1, 1, 10, and 100µg/mL, in order
to test for the absence of cytotoxicity over a large range
of concentrations. The ﬁnal concentration of ethanol in all
dilutions was less than 1%.
2.2. Cell Lines. Two human breast cancer cell lines (MCF-7
and HTB126), three human pancreatic cancer cells (Panc-1,
Mia-Paca2, and Capan1), and a human foreskin ﬁbroblast
celllineofHs68wereusedonthisstudy.Allsixcelllineswere
purchased from ATCC (Rockville, Md, USA). The cells were
cultured and grown at 37◦C and 5% CO2 in sterile DMEM
medium with 10% fetal bovine serum (MCF-7, HTB126,
Panc-1,andHs68),DMEMwith10%fetalbovineserumand
2.5% horse serum (Mia-Paca2), and IMDM with 20% fetal
bovine serum (Capan1), after the addition of glutamine and
penicillin-streptomycin. Cells were grown in standard tissue
culture ﬂasks and were passaged with a solution of 0.25%
trypsin-EDTA upon reaching 80% conﬂuence.
2.3. Cytotoxicity Analysis with MTT Assay. Cytotoxicity of
the plant extracts on the cell lines was determined using the
MTT Proliferation Assay kits from ATCC and Sigma Aldrich.
The assay is based on the conversion of yellow tetrazolium
salt MTT to purple formazan crystals by metabolically active
cells. The amount of formazan produced is proportional to
the number of viable cells. Cells were seeded in 96-well ﬂat
bottom tissue culture plates at a density of approximatelyEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Schematic and operation of photonic crystal biosensor and readout instrument. An illuminating LED (white arrows) is normally
incident to the surface of biosensor, and the reﬂected light (red arrows) is collected through a detecting ﬁber into a spectrometer, which
measures the reﬂected peak wavelength shift from biomolecular or cellular binding.
1–1.2 × 104 cells/well and allowed to attach for 24 hours at
37◦C. The cells were then incubated with 100µLo fe x t r a c t s
at 100µg/mL for 24 hours. Control cultures received 100µL
of medium, and blank wells without cells contained 100µL
of medium. After the drug exposure period, the cells were
grown for additional 24 hours in extract-free fresh medium.
Av o l u m eo f1 0µL of the MTT reagent was then added to
each well, and the plate was incubated for 4h at 37◦C. The
MTT crystals were then solubilized overnight with 100µL
of the MTT detergent reagent. Absorbance measurements
were made at 570nm using a Biotek HT Spectrophotometer.
Cytotoxicity was expressed as the percentage of cells surviv-
ing relative to untreated cultures. All MTT experiments were
performed in triplicates and repeated twice.
2.4. Cytotoxicity Analysis with PC Assay. The sensor and
instrumentationofthePCassaymethodhavebeendescribed
previously in [23–27]. The biosensor measures changes in
the wavelength of reﬂected light or peak wavelength value
(PWV) as biochemical or cellular binding events take place
on the surface. The imaging instrument (SRU Biosystems,
Woburn, Mass, USA) illuminates the photonic crystal at
normal incidence with white light, and PWV of each pixel
is imaged into the entrance slit of an imaging spectrometer
(Figure 1).
The 96-well PC biosensor microplates were utilized to
conﬁrm the cytotoxicity eﬀects of the Amoora extracts on the
breast cancer cell MCF-7. An initial scan with the cell culture
media was taken for the background image. Approximately
500–1000 cells were seeded in the biosensor, and the cells
were allowed to attach and grow for 24 hours. A second
scan was performed after the 24-hour incubation. The cells
were then incubated with the plant extracts at the same
concentrations as the MTT assay for another 24 hours after
which a ﬁnal scan was performed (Figure 2). The initial cell
count prior to incubation was used as a reference; thus the
proliferation or cytotoxic eﬀect can be determined. The PC
cell-based assay has been published previously [11, 21, 28].
2.5. Statistical Analysis. In order to test if the cytotoxicity
diﬀerence between the control and plant extracts was signif-
icant, one-way ANOVA was used to compare the diﬀerent
treatment groups followed by Tukeys multiple comparison
tests wherever necessary.
3. Results
3.1. In Vitro Response with the MTT Assay. The dose-
dependent responses for the breast cancer cells are shown
in Figure 3. Upon treating MCF-7 cancer cells (Figure 3(a)),
the chittagonga species were cytotoxic and showed IC50
values of ∼42µg/mL and 48µg/mL for the Pet-Ether and
CH2Cl2 extracts, respectively. Upon treatment with the
species of rohituka, the Pet-Ether extract showed an IC50
of ∼41µg/mL. However, the chittagonga EtoAC and the
rohituka MeOH extracts were not cytotoxic to the MCF-74 Evidence-Based Complementary and Alternative Medicine
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Figure 2: PC biosensor cancer cell imaging protocol: (a) initial baseline scan, (b) cancer cell immobilization scan after 24-hour incubation,
and (c) eﬀect of plant extracts after 24-hour incubation.
Table 1: IC50 values and eﬀects of ﬁve Amoora plant extracts on the six cell lines. Note that only normal ﬁbroblast cell line has no eﬀect for
each extract.
MCF-7 HTB126 Panc-1 Mia-Paca2 Capan-1 Hs68
chittagonga Pet-Ether 42µg/mL No Eﬀect No Eﬀect No Eﬀect No Eﬀect No Eﬀect
chittagonga CH2Cl2 48µg/mL 43µg/mL 39µg/mL 30µg/mL 65µg/mL No Eﬀect
chittagonga EtoAC No Eﬀect No Eﬀect No Eﬀect No Eﬀect No Eﬀect No Eﬀect
rohituka Pet-Ether 41µg/mL No Eﬀect No Eﬀect No Eﬀect No Eﬀect No Eﬀect
rohituka MeOH No Eﬀect No Eﬀect No Eﬀect No Eﬀect No Eﬀect No Eﬀect
cancer cells. Treatment of HTB126 cancer cells revealed
that (Figure 3(b)) only the chittagonga CH2Cl2 extract was
cytotoxic,andhereanIC50 valueof∼43µg/mLwasobserved.
The dose response curves for the pancreatic cancer cells are
shown in Figure 4. Treatment of Panc-1, Mia-Paca2, and
Capan-1cancercellrevealedthat(Figures4(a)–4(c))onlythe
chittagonga CH2Cl2 extract showed signiﬁcant cytotoxicity
with IC50 values of ∼39µg/mL, 30µg/mL, and 65µg/mL,
respectively. The normal ﬁbroblast Hs68 cells did not exhibit
cytotoxic eﬀect with any extract, indicating the potential
speciﬁcity of the Amoora extracts against target cancer cells
(Figure 5).
Forextractsthatshowedcytotoxicactivity,thediﬀerences
between the control and treatment groups were signiﬁcantly
diﬀerent (P<. 05). For extracts that did not suppress cell
proliferation, the diﬀerence in the means is not signiﬁcant
compared to the control (P>. 05), thus statistically
conﬁrming that these Amoora extracts are not cytotoxic at
any of the above tested dose levels.
3.2. In Vitro Response with the PC Assay. For the assay
employing the photonic crystal biosensor system, each well
wasscannedbeforeandaftertreatmentwiththedrug.Hence,
for the analysis of each extract, the cell count after drug
treatment was compared with the cell count of the negative
control (no drug exposure). Consistent with the results
obtained using the MTT assay, the Pet-Ether and CH2Cl2
fractions of Amoora chittagonga and Pet-Ether fraction
of Amoora rohituka showed IC50 values at ∼40µg/mL,
51µg/mL, and 38µg/mL, respectively (Figure 6). The other
two extracts, chittagonga EtoAC and MeOH, did not show
any cytotoxicity but instead showed proliferation of cancer
cells to 4 times the control wells (data not shown).
3.3. Correlation of the Two Methods. The photonic crystal
and the MTT assay showed good correlation for the three
fractions of Amoora compounds that were eﬀective against
theMCF-7.ThecorrelationplotisshowninFigure 7.Forthe
cytotoxic fractions of Amoora chittagonga Pet-Ether, CH2Cl2,
and rohituka Pet-Ether, the correlation coeﬃcients for MCF7
cells are 0.909, 0.715, and 0.922, respectively.
4. Discussion
As seen from the results of the MTT and PC assays, the
Amoora extracts induced varying levels of cytotoxicity on
diﬀerent cell lines within the same category. It must be noted
that, for each species, all samples obtained using diﬀerent
extraction methods were dried and resuspended in ethanol
to eliminate uncertainty that might arise from the diﬀerent
extraction solvents. These stock solutions were then diluted
using cell culture media for the dose response studies. For
the breast cancer cells, three of the extracts exhibited high
cytotoxicity eﬀect on the MCF-7 cell line, whereas only one
extract was cytotoxic to the HTB126 cells. We hypothesize
that the diﬀerences between MCF-7 and HTB126 may have
been due to their susceptibility to Amoora plant extracts
[29,30].ThechittagongaCH2Cl2 extractwashighlycytotoxic
to both breast cancer cell lines and also caused noticeable
cytotoxicity to all three pancreatic cancer cell lines. All other
Amoora extractsinducedminimallevelsofcytotoxicitytothe
pancreatic cancer cells.
The eﬀects of the extracts on the cancer cells are
shown in Table 1. The Pet-ether of Amoora chittagonga
aﬀected only the MCF-7 (IC50∼ 42µg/mL) and had little
or no eﬀect on the other cancer cell lines. The Amoora
chittagonga CH2Cl2 aﬀected MCF-7 (∼48µg/mL), HTB126Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Plot of survival fraction percentage of breast cancer cells,
(a) MCF-7 and (b) HTB126 cell lines, in response to the Amoora
compounds. Cultured MCF-7 and HTB126 cells were induced with
chittagonga (Pet-Ether, CH2Cl2, and EtoAC) and rohituka (Pet-
Ether and MeOH) for 24 hours before performing the MTT assay.
The IC50 values for MCF-7 in response to the chittagonga Pet-Ether,
CH2Cl2,a n drohituka Pet-Ether were ∼42µg/mL, 48µg/mL, and
41µg/mL, respectively. For HTB126, only the chittagonga CH2Cl2
induced cytotoxicity at an IC50 of ∼43µg/mL.
(∼43µg/mL), Panc-1 (∼39µg/mL), Mia-Paca2 (30µg/mL),
and Capan-1 (∼65µg/mL) cell lines. Although the IC50
values diﬀer between the eﬀective extracts of Amoora chit-
tagonga, we calculated the signiﬁcance of the cytotoxicity for
MCF-7 and showed that the two fractions did not signiﬁ-
cantly diﬀer in their cytotoxic potential (P>. 05). The Ethyl
acetate (EtoAC) partitionate of Amoora chittagonga did not
aﬀect the proliferation of any of the cancer cell lines as seen
from the MTT results. The eﬃcacy of the ethyl acetate parti-
tionate was signiﬁcantly diﬀerent from that of the Petroleum
ether and the CH2Cl2 fractions (P<. 05). The rohituka Pet-
Ether extract was eﬀective against MCF-7 (consistent with
the previous literature [31]), but not the other cell lines. Two
independent fractions of Amoora rohituka diﬀered signiﬁ-
cantly in their eﬀectiveness (P<. 05), wherein the petroleum
ether extract was highly cytotoxic against the cancer cells and
the MeOH extract had no eﬀect on the cell proliferation. The
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.1
1.2
1.3
1.4
S
u
r
v
i
v
a
l
f
r
a
c
t
i
o
n
(
%
)
0 1 02 03 04 05 06 07 08 09 0 1 0 0
Concentration (µg/mL)
1.0
(a)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.1
1.2
1.3
1.4
S
u
r
v
i
v
a
l
f
r
a
c
t
i
o
n
(
%
)
0 1 02 03 04 05 06 07 08 09 0 1 0 0
Concentration (µg/mL)
1.0
(b)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.1
1.2
1.3
1.4
S
u
r
v
i
v
a
l
f
r
a
c
t
i
o
n
(
%
)
0 1 02 03 04 05 06 07 08 09 0 1 0 0
Concentration (µg/mL)
chittagonga Pet-Ether
chittagonga CH2Cl2
chittagonga EtoAC
rohituka Pet-Ether
rohituka MeOH
1.0
(c)
Figure 4: Plot of survival fraction percentage of pancreatic cancer
cells, (a) Panc-1, (b) Mia-Paca2, and (c) Capan-1 cell lines,
in response to the Amoora compounds. Cultured Panc-1, Mia-
Paca2, and Capan-1 cells were induced with chittagonga (Pet-Ether,
CH2Cl2, and EtoAC) and rohituka (Pet-Ether and MeOH) for 24
hours before performing the MTT assay. Out of the ﬁve Amoora
extracts, only the chittagonga CH2Cl2 induced cytotoxicity in the
threepancreaticcancercelllines,withtheIC50 valuesof ∼39µg/mL,
30µg/mL, and 65µg/mL, respectively.
varying results from a single species of Amoora plant suggest
that the partitioning of plant extracts using diﬀerent solvents
may have a signiﬁcant inﬂuence on the biological activity6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Plot of survival fraction percentage of normal ﬁbroblast
Hs68 cell line. Cultured Hs68 cells were induced with chittagonga
(Pet-Ether, CH2Cl2, and EtoAC) and rohituka (Pet-Ether and
MeOH) for 24 hours before performing the MTT assay. Minimal
eﬀect on the ﬁbroblast cell line was observed from each Amoora
species (IC50 > 100µg/mL).
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Figure 6: Plot of percent survival fraction of MCF-7 cells in
response to Amoora compounds using PC biosensor assay as a
veriﬁcation method for the MTT assays. Cultured MCF-7 cells were
induced with cytotoxic chittagonga (Pet-Ether and CH2Cl2)a n d
rohituka (Pet-Ether) identiﬁed from the MTT assay. The IC50 values
of the three extracts, chittagonga Pet-Ether, CH2Cl2,a n drohituka
Pet-Ether, are ∼40µg/mL, 51µg/mL, and 38µg/mL, respectively.
of the resulting fraction. Only chittagonga CH2Cl2 induced
cytotoxicity in all ﬁve cancer cell lines. We hypothesized
that the diﬀerence between the cytotoxicity of rohituka
and chittagonga may have been caused by the content of
amooranin within the extracts. Most of the current studies
involving Amoora rohituka extract showed considerable
antitumor eﬀect, but it seemed that Amoora chittagonga
wouldalsobeanattractiveextracttofurtherexploreindepth
its anticancer properties. The cytotoxicity diﬀerence between
the ﬁve cancer cell lines and normal cell line suggested
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Figure 7: Correlation between the viability of MCF-7 cells mea-
sured using the photonic crystal assay and the MTT assay for
Amoora chittagonga (Pet-ether and MeOH extract) and Amoora
rohituka (Pet-ether extract), which veriﬁed cytotoxicity results
obtained from the MTT assay.
that Amoora plants extracts may aﬀect speciﬁc cancer cell
lines.
In order to rapidly examine a group of cancer cell lines
against a library of plant extracts, it is necessary to utilize
a high-throughput screening technology. The testing of the
extracts could be easily facilitated using the photonic crystal
sensor assay, which senses attachment of viable cells and
produces a signal that can be quantiﬁed in terms of the
cell numbers. If the cells become apoptotic or necrotic
in response to the concentration of the drug, they lose
attachment with the sensor surface, and this results in a
weak or no signal at the point of attachment. The advantage
conferred by this method is that a vast library of compounds
can be simultaneously tested without the need for any
ﬂuorescent labeling markers or other colorimetric assays.
The PC biosensor assay is used to verify the cytotoxicity
eﬀect of Amoora extracts identiﬁed by the MTT assay. The
results of the PC assay correlate closely with that of the MTT
assay performed under similar experimental conditions. In
addition, the PC biosensor assay is able to observe label-free
images of proliferation and cytotoxicity of clusters of cancer
cells in a well from the Amoora plant extracts, whereas the
MTT assay only provides a bulk colorimetric response for
a given well. The PC assay was performed on only MCF-7
cell line to show the capability in detecting cytotoxic eﬀect of
plant extracts compared to MTT assay. We have previously
demonstrated the use of the PC method for accurate high-
throughput screening of a library of plant extracts [28].
Based on our results, a study of the active ingredients in
the Amoora chittagonga plant extract that are responsible for
cancer-speciﬁc cytotoxicity eﬀects is warranted.Evidence-Based Complementary and Alternative Medicine 7
5. Conclusion
Inthiswork,wehavefurtherexploredthetherapeuticaleﬀect
of the Amoora plant extracts against ﬁve cancer cell lines.
Although numerous studies have reported medicinal and
therapeutic eﬀects of the Amoora extracts, it is important
to examine the eﬀects of unreported Amoora species against
speciﬁc cancer cell lines in an eﬀort to identify preliminary
candidates for alternative cancer therapeutics. By employing
the MTT assay, various cytotoxicity eﬀects were observed
for a combination of ﬁve Amoora extracts and ﬁve cancer
cell lines. Interestingly, when samples of a species of the
Amoora plant were extracted using diﬀerent extraction
methods, we found that these crude extracts showed varying
levels of cytotoxicity on the cancer cells. By identifying the
active Amoora extracts on speciﬁc cancer cell lines, further
research could be performed on examining the biochemical
compositions to fully understand the mechanism of the
cytotoxicity eﬀects.
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